Literature DB >> 26200678

DNA Mismatch Repair Status Predicts Need for Future Colorectal Surgery for Metachronous Neoplasms in Young Individuals Undergoing Colorectal Cancer Resection.

Melyssa Aronson1, Spring Holter, Kara Semotiuk, Laura Winter, Aaron Pollett, Steven Gallinger, Zane Cohen, Robert Gryfe.   

Abstract

BACKGROUND: The treatment of colorectal cancer in young patients involves both management of the incident cancer and consideration of the possibility of Lynch syndrome and the development of metachronous colorectal cancers.
OBJECTIVE: This study aims to assess the prognostic role of DNA mismatch repair deficiency and extended colorectal resection for metachronous colorectal neoplasia risk in young patients with colorectal cancer. DESIGN, SETTING, AND PATIENTS: This is a retrospective review of 285 patients identified in our GI cancer registry with colorectal cancer diagnosed at 35 years or younger in the absence of polyposis. MAIN OUTCOME MEASURES: Using univariate and multivariate analysis, we assessed the prognostic role of mismatch repair deficiency and standard clinicopathologic characteristics, including the extent of resection, on the rate of developing metachronous colorectal neoplasia requiring resection.
RESULTS: Mismatch repair deficiency was identified in biospecimens from 44% of patients and was significantly associated with an increased risk for metachronous colorectal neoplasia requiring resection (10-year cumulative risk, 13.5% ± 4.2%) compared with 56% of patients with mismatch repair-intact colorectal cancer (10-year cumulative risk, 5.8% ± 3.3%; p = 0.011). In multivariate analysis, mismatch repair deficiency was associated with a HR of 3.65 (95% CI, 1.44-9.21; p = 0.006) for metachronous colorectal neoplasia, whereas extended resection with ileorectal or ileosigmoid anastomosis significantly decreased the risk of metachronous colorectal neoplasia (HR, 0.21; 95% CI, 0.05-0.90; p = 0.036). LIMITATIONS: This study had a retrospective design, and, therefore, recommendations for colorectal cancer surgery and screening were not fully standardized. Quality of life after colorectal cancer surgery was not assessed.
CONCLUSIONS: Young patients with colorectal cancer with molecular hallmarks of Lynch syndrome were at significantly higher risk for the development of subsequent colorectal neoplasia. This risk was significantly reduced in those who underwent extended resection compared with segmental resection.

Entities:  

Mesh:

Year:  2015        PMID: 26200678     DOI: 10.1097/DCR.0000000000000391

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  7 in total

1.  Response to letter to editor regarding published article-metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis.

Authors:  Mark P Lythgoe; Salim S Malik; Mark McPhail; Kevin J Monahan
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

2.  Letter to the editor.

Authors:  C C Anele; A Latchford; O Faiz; S K Clark
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  Mismatch Repair Proteins in Oropharyngeal Squamous Cell Carcinoma: A Retrospective Observational Study.

Authors:  Osias Vieira de Oliveira Filho; Thinali Sousa Dantas; Isabelle Joyce de Lima Silva-Fernandes; Maria do Perpétuo Socorro Saldanha Cunha; Ana Paula Negreiros Nunes Alves; Mário Rogério Lima Mota; Paulo Goberlânio de Barros Silva; Fabrício Bitu Sousa
Journal:  Head Neck Pathol       Date:  2021-01-27

4.  Colorectal cancer in young adults: A difficult challenge.

Authors:  Fábio Guilherme Campos
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

5.  Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis.

Authors:  Salim S Malik; Mark P Lythgoe; Mark McPhail; Kevin J Monahan
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

6.  PMS2: a potential prognostic protein marker in oral squamous cell carcinoma.

Authors:  J-M Decker; O-V Filho; M-O Freitas; I-J Silva-Fernandes; T-S Dantas; C-S Campêlo; M-D Cunha; P-G Silva; F-B Sousa
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-07-01

7.  Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.

Authors:  Nuria Dueñas; Matilde Navarro; Àlex Teulé; Ares Solanes; Mònica Salinas; Sílvia Iglesias; Elisabet Munté; Jordi Ponce; Jordi Guardiola; Esther Kreisler; Elvira Carballas; Marta Cuadrado; Xavier Matias-Guiu; Napoleón de la Ossa; Joan Lop; Conxi Lázaro; Gabriel Capellá; Marta Pineda; Joan Brunet
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.